Liu CQ, Ma YL, Qin Q, Wang PH, Luo Y, Xu PF, et al. Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040. Thoracic cancer. 2023;14(1):3–11. https://doi.org/10.1111/1759-7714.14745.
Peery AF, Crockett SD, Barritt AS, Dellon ES, Eluri S, Gangarosa LM, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149(7):1731-41.e3. https://doi.org/10.1053/j.gastro.2015.08.045.
Watanabe M, Otake R, Kozuki R, Toihata T, Takahashi K, Okamura A, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today. 2020;50(1):12–20. https://doi.org/10.1007/s00595-019-01878-7.
Waters JK, Reznik SI. Update on management of squamous cell esophageal cancer. Curr Oncol Rep. 2022;24(3):375–85. https://doi.org/10.1007/s11912-021-01153-4.
Article CAS PubMed Google Scholar
Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–8. https://doi.org/10.1038/nrc1074.
Article CAS PubMed Google Scholar
Ku GY. Systemic therapy for esophageal cancer: chemotherapy. Chin Clin Oncol. 2017;6(5):49. https://doi.org/10.21037/cco.2017.07.06.
Ciardiello D, Martini G, Famiglietti V, Napolitano S, De Falco V, Troiani T, et al. Biomarker-guided anti-egfr rechallenge therapy in metastatic colorectal cancer. Cancers (Basel). 2021. https://doi.org/10.3390/cancers13081941.
Kojima T, Shah MA, Muro K, Francois E, Adenis A, Hsu CH, et al. Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer. J Clin Oncol. 2020;38(35):4138–48. https://doi.org/10.1200/jco.20.01888.
Article CAS PubMed Google Scholar
Wang C, Zhou M, Zhu P, Ju C, Sheng J, Du D, et al. IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis. J Exp Clin Cancer Res. 2022;41(1):347. https://doi.org/10.1186/s13046-022-02550-8.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Yang W, Wang Q, Zhou Y. Mechanisms of esophageal cancer metastasis and treatment progress. Front Immunol. 2023;14:1206504. https://doi.org/10.3389/fimmu.2023.1206504.
Article CAS PubMed PubMed Central Google Scholar
Huang M, Lu JJ, Ding J. Natural products in cancer therapy: past present and future. Nat Prod Bioprospect. 2021;11(1):5–13. https://doi.org/10.1007/s13659-020-00293-7.
Article PubMed PubMed Central Google Scholar
Karpanen TJ, Worthington T, Hendry ER, Conway BR, Lambert PA. Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidis. J Antimicrob Chemother. 2008;62(5):1031–6. https://doi.org/10.1093/jac/dkn325.
Article CAS PubMed Google Scholar
Nagoor Meeran MF, Javed H, Al Taee H, Azimullah S, Ojha SK. Pharmacological properties and molecular mechanisms of thymol: prospects for its therapeutic potential and pharmaceutical development. Front Pharmacol. 2017;8:380. https://doi.org/10.3389/fphar.2017.00380.
Article CAS PubMed PubMed Central Google Scholar
Aljelehawy QHA, Mohammadi S, Mohamadian E, RajiMalAllah O, Mirzaei A, Ghahremanlou M. Antimicrobial, anticancer, antidiabetic, antineurodegenerative, and antirheumatic activities of thymol: clarification of mechanisms. Micro Nano Bio Aspects. 2023;2(1):1–7. https://doi.org/10.22034/mnba.2023.381107.1019.
Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019. https://doi.org/10.1056/NEJMra1713263.
Li Y, Wen JM, Du CJ, Hu SM, Chen JX, Zhang SG, et al. Thymol inhibits bladder cancer cell proliferation via inducing cell cycle arrest and apoptosis. Biochem Biophys Res Commun. 2017;491(2):530–6. https://doi.org/10.1016/j.bbrc.2017.04.009.
Article CAS PubMed Google Scholar
De La Chapa JJ, Singha PK, Lee DR, Gonzales CB. Thymol inhibits oral squamous cell carcinoma growth via mitochondria-mediated apoptosis. J Oral Pathol Med. 2018;47(7):674–82. https://doi.org/10.1111/jop.12735.
Article CAS PubMed Google Scholar
Chauhan AK, Bahuguna A, Paul S, Kang SC. Thymol elicits HCT-116 colorectal carcinoma cell death through induction of oxidative stress. Anticancer Agents Med Chem. 2018;17(14):1942–50. https://doi.org/10.2174/1871520617666170327121228.
Article CAS PubMed Google Scholar
Fekri Kohan S, Zamani H, Salehzadeh A. Antibacterial potential and cytotoxic activity of iron oxide nanoparticles conjugated with thymol (Fe(3)O(4)@Glu-thymol) on breast cancer cells and investigating the expression of BAX, CASP8, and BCL-2 genes. Biometals. 2023;36(6):1273–84. https://doi.org/10.1007/s10534-023-00516-7.
Article CAS PubMed Google Scholar
Qoorchi Moheb Seraj F, Heravi-Faz N, Soltani A, Ahmadi SS, Shahbeiki F, Talebpour A, et al. Thymol has anticancer effects in U-87 human malignant glioblastoma cells. Mol Biol Rep. 2022;49(10):9623–32. https://doi.org/10.1007/s11033-022-07867-3.
Article CAS PubMed Google Scholar
Martinotti S, Ranzato E. Scratch wound healing assay. Methods Mol Biol. 2020;2109:225–9. https://doi.org/10.1007/7651_2019_259.
Article CAS PubMed Google Scholar
Toth M, Fridman R. Assessment of gelatinases (MMP-2 and MMP-9 by gelatin zymography. Methods Mol Med. 2001;57:163–74. https://doi.org/10.1385/1-59259-136-1:163.
Article CAS PubMed Google Scholar
Takeuchi H, Miyata H, Gotoh M, Kitagawa Y, Baba H, Kimura W, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260(2):259–66. https://doi.org/10.1097/sla.0000000000000644.
Mao C, Zeng X, Zhang C, Yang Y, Xiao X, Luan S, et al. Mechanisms of pharmaceutical therapy and drug resistance in esophageal cancer. Front Cell Dev Biol. 2021;9: 612451. https://doi.org/10.3389/fcell.2021.612451.
Article PubMed PubMed Central Google Scholar
Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Targeting drug chemo-resistance in cancer using natural products. Biomedicines. 2021;9(10):1353. https://doi.org/10.3390/biomedicines9101353.
Article CAS PubMed PubMed Central Google Scholar
Blažíčková M, Blaško J, Kubinec R, Kozics K. Newly synthesized thymol derivative and its effect on colorectal cancer cells. Molecules. 2022. https://doi.org/10.3390/molecules27092622.
Article PubMed PubMed Central Google Scholar
Yeh JH, Chou CT, Chen IS, Lu T, Lin KL, Yu CC, et al. Effect of thymol on Ca2+ homeostasis and viability in PC3 human prostate cancer cells. Chin J Physiol. 2017;60(1):32–40. https://doi.org/10.4077/cjp.2017.Baf447.
Article CAS PubMed Google Scholar
Dashtaki A, Mahjoub S, Zabihi E, Pourbagher R. The effects of pre-treatment and post-treatment of thymol against tert-butyl hydroperoxide (t-BHP) cytotoxicity in MCF-7 cell line and fibroblast derived foreskin. Rep Biochem Mol Biol. 2020;9(3):338–47. https://doi.org/10.29252/rbmb.9.3.338.
Article CAS PubMed PubMed Central Google Scholar
Deb DD, Parimala G, Saravana Devi S, Chakraborty T. Effect of thymol on peripheral blood mononuclear cell PBMC and acute promyelotic cancer cell line HL-60. Chem Biol Interact. 2011;193(1):97–106. https://doi.org/10.1016/j.cbi.2011.05.009.
Article CAS PubMed Google Scholar
Ahmed OM, Galaly SR, Mostafa M-AMA, Eed EM, Ali TM, Fahmy AM, et al. Thyme oil and thymol counter doxorubicin-induced hepatotoxicity via modulation of inflammation, apoptosis, and oxidative stress. Oxid Med Cell Longev. 2022;2022:6702773. https://doi.org/10.1155/2022/6702773.
Article CAS PubMed PubMed Central Google Scholar
EM E-S, AR A-A, AM M, AA E-A. Thymol and carvacrol prevent cisplatin-induced nephrotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in rats. Oxid Med Cell Longev. 2015;29(4):165–72. https://doi.org/10.1002/jbt.21681.
Vadlapatla RK, Vadlapudi AD, Pal D, Mitra AK. Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes. Curr Pharm Des. 2013;19(40):7126–40. https://doi.org/10.2174/13816128113199990493.
Article CAS PubMed Google Scholar
Elbe H, Yigitturk G, Cavusoglu T, Uyanikgil Y, Ozturk F. Apoptotic effects of thymol, a novel monoterpene phenol, on different types of cancer. Bratisl Lek Listy. 2020;121(2):122–8. https://doi.org/10.4149/bll_2020_016.
留言 (0)